Viewing Study NCT05012150


Ignite Creation Date: 2025-12-24 @ 5:08 PM
Ignite Modification Date: 2026-01-16 @ 12:39 AM
Study NCT ID: NCT05012150
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-10-24
First Post: 2021-07-27
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Pilot Study in Endoscopic Therapy on Quality of Life and Pain in Chronic Pancreatitis
Sponsor: Ohio State University
Organization:

Study Overview

Official Title: A Pilot Study in Endoscopic Therapy on Quality of Life and Pain in Chronic Pancreatitis: The EQuiPP Study
Status: ACTIVE_NOT_RECRUITING
Status Verified Date: 2025-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: EQuiPP
Brief Summary: This study is a prospective study designed to assess the effect of pancreatic endotherapy on quality of life, pain levels, pancreatic exocrine function, and endocrine function.
Detailed Description: Pancreatic endotherapy represents a potential treatment modality for patients with painful chronic pancreatitis. While pancreatic endotherapy is commonly performed, the effect of chronic pancreatitis on patient-centered outcomes remains poorly studied. Furthermore, the effect of endotherapy on pancreatic endocrine and exocrine are largely unknown. This study therefore aims to prospective observe patients with chronic pancreatitis after endotherapy is performed to better understand how it affects patient-centered outcomes such as pain and quality of life and pancreatic function. In doing so, the study also hopes to be able to predict which patients with chronic pancreatitis will benefit from pancreatic endotherapy.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: False
Is an FDA AA801 Violation?: